⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24984659 | 0.92 | — | — | |
| SCHEMBL26526003 | 0.86 | CYP2C9 (0.32) | — | |
| SCHEMBL23905461 | 0.85 | — | — | |
| SCHEMBL23195598 | 0.85 | GRM2 (0.34) | — | |
| SCHEMBL26537778 | 0.85 | GRM2 (0.34) | — | |
| SCHEMBL23195987 | 0.82 | CFTR (0.31) | — | |
| SCHEMBL23195580 | 0.82 | — | — | |
| SCHEMBL23905363 | 0.82 | — | — | |
| SCHEMBL23905842 | 0.81 | — | — | |
| SCHEMBL23905402 | 0.81 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11572367-B2 | Antiviral heterocyclic compounds | ENANTA PHARMACEUTICALS, INC. (US) | 2023-02-07 | — | — | US | disclosed |
| WO-2021066922-A1 | ANTIVIRAL HETEROCYCLIC COMPOUNDS | ENANTA PHARMACEUTICALS, INC. (US) | 2021-04-08 | — | — | WO | disclosed |